Table 4.
Relative mRNA transcription (%) of Flt1 and KDR in leukocytes
B type ALL de novo patients | T type ALL de novo patients | AML patients | Relapse (refractory) patients | Remission group | Healthy children | |
---|---|---|---|---|---|---|
Flt-1 | 68.3 ± 16.1▲▲,ΔΔ | 59.1± 8.6□,▲,ΔΔ | 79.7 ± 25.7▲,Δ | 100 ± 19.9▲▲▲,ΔΔ | 38.1 ± 13.1 | 31.9 ± 8.4 |
KDR | 49.9 ± 11.9□□,▲▲▲,ΔΔ | 44.9 ± 13.8□□,▲▲▲ | 69.2 ± 31.6▲▲,Δ | 100 ± 33.0▲▲▲,ΔΔ | 18.6 ± 4.8 | 24.2 ± 8.3 |
P < 0.05, compared to relapse patients;
P < 0.01, compared to relapse patients;
P < 0.05, compared to remission group;
P < 0.01, compared to remission group;
P < 0.001, compared to remission group;
P < 0.05, compared to healthy children;
P <0.01 compared to healthy children.